Design, findings and implications of the liraglutide Phase III clinical trial program-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, findings and implications of the liraglutide Phase III clinical trial program

Published:2012-01 Issue:1 Volume:2 Page:59-72
ISSN:2041-6792
Container-title:Clinical Investigation
language:en
Short-container-title:Clinical Investigation

Author:

Bode Bruce W

Publisher

OMICS Publishing Group

Subject

General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care;Biomedicines;2024-09-07

2. Type 2 Diabetes Remission with Significant Weight Loss: Definition and Evidence-Based Interventions;Journal of Obesity & Metabolic Syndrome;2022-05-27

3. Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists;Advances in Therapy;2021-05-11

4. Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels;JAMA Network Open;2020-02-07

5. Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide;Diabetes Care;2018-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP